Added to YB: 2026-08-17
Pitch date: 2026-08-14
WGS [neutral]
GeneDx Holdings Corp.
Author Info
Company Info
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Market Cap
$2.4B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
-95.28
P/E
-21.75
EV/Sales
5.27
Sector
Health Care Providers and Services
Category
turnaround
3 Small-Caps in 3 Minutes #10 - Mexican Investor - GeneDx Holdings Corp.
WGS (quick overview): Rare disease genomic testing w/ 1M+ exome/genome database creating data flywheel. Stock -65% from Nov highs after reimbursement cuts forced 2026 rev guide cut ($540-555M to $475-490M). But demand strong: record 30,785 tests (+32% YoY). Trades 4.6x fwd EV/S vs 6x industry median, NTRA & GH higher. Author sees temporary problem, market too pessimistic. $2.46B mkt cap, $34.9M net debt.
Read full article (1 min)